SkinMedica® Revolutionizes Skin Hydration with the Introduction of HA5® Hydra Collagen Replenish + Restore Hydrator
SkinMedica®, a brand under Allergan Aesthetics (an AbbVie company, NYSE: ABBV), has launched its new HA5® Hydra Collagen Replenish + Restore Hydrator. This innovative product, designed for all skin types, features:
- Double the amount of hyaluronic acid compared to the original formula
- Hydra Collagen and Advanced VITISENSCE® Technology
- Up to 48 hours of hydration
- Support for the skin's natural moisture retention
The product can be complemented with an in-office DiamondGlow® facial using SkinMedica® HA5® Hydra Collagen Pro-Infusion Serum. Clinical studies show this combination results in skin appearing three times more radiant, hydrated, and visibly plumper after one use.
SkinMedica®, un marchio di Allergan Aesthetics (una società AbbVie, NYSE: ABBV), ha lanciato il suo nuovo HA5® Hydra Collagen Replenish + Restore Hydrator. Questo prodotto innovativo, progettato per tutti i tipi di pelle, presenta:
- Il doppio della quantità di acido ialuronico rispetto alla formula originale
- Hydra Collagen e tecnologia avanzata VITISENSCE®
- Fino a 48 ore di idratazione
- Supporto per la naturale ritenzione dell'umidità della pelle
Il prodotto può essere abbinato a un trattamento viso DiamondGlow® in studio, utilizzando il SkinMedica® HA5® Hydra Collagen Pro-Infusion Serum. Studi clinici dimostrano che questa combinazione rende la pelle tre volte più radiosa, idratata e visibilmente più piena dopo un solo utilizzo.
SkinMedica®, una marca de Allergan Aesthetics (una compañía de AbbVie, NYSE: ABBV), ha lanzado su nuevo HA5® Hydra Collagen Replenish + Restore Hydrator. Este producto innovador, diseñado para todo tipo de piel, presenta:
- El doble de cantidad de ácido hialurónico en comparación con la fórmula original
- Hydra Collagen y tecnología avanzada VITISENSCE®
- Hasta 48 horas de hidratación
- Soporte para la retención natural de humedad de la piel
El producto puede complementarse con un facial DiamondGlow® en el consultorio utilizando el SkinMedica® HA5® Hydra Collagen Pro-Infusion Serum. Los estudios clínicos muestran que esta combinación hace que la piel aparezca tres veces más radiante, hidratada y visiblemente más firme después de un solo uso.
SkinMedica®는 Allergan Aesthetics의 브랜드로 (AbbVie의 회사, NYSE: ABBV), 새로운 HA5® Hydra Collagen Replenish + Restore Hydrator를 출시했습니다. 모든 피부 타입을 위해 설계된 이 혁신적인 제품은 다음을 포함합니다:
- 원래 포뮬러에 비해 하이알루론산 함량이 두 배
- Hydra Collagen 및 고급 VITISENSCE® 기술
- 최대 48시간 수분 유지
- 피부의 자연 수분 유지 지원
이 제품은 SkinMedica® HA5® Hydra Collagen Pro-Infusion Serum을 사용한 DiamondGlow® 페이셜과 함께 사용할 수 있습니다. 임상 연구에 따르면 이 조합은 단 한번 사용 후 피부가 3배 더 빛나고, 수분이 풍부하며, 눈에 띄게 탄력 있어 보인다고 합니다.
SkinMedica®, une marque d'Allergan Aesthetics (une société d'AbbVie, NYSE: ABBV), a lancé son nouveau HA5® Hydra Collagen Replenish + Restore Hydrator. Ce produit innovant, conçu pour tous les types de peau, présente :
- Le double de la quantité d'acide hyaluronique par rapport à la formule originale
- Hydra Collagen et technologie avancée VITISENSCE®
- Jusqu'à 48 heures d'hydratation
- Soutien à la rétention naturelle d'humidité de la peau
Le produit peut être complété par un soin du visage DiamondGlow® en cabinet utilisant le SkinMedica® HA5® Hydra Collagen Pro-Infusion Serum. Des études cliniques montrent que cette combinaison rend la peau trois fois plus radieuse, hydratée et visiblement plus rebondie après une seule utilisation.
SkinMedica®, eine Marke von Allergan Aesthetics (ein AbbVie Unternehmen, NYSE: ABBV), hat seinen neuen HA5® Hydra Collagen Replenish + Restore Hydrator auf den Markt gebracht. Dieses innovative Produkt, das für alle Hauttypen entwickelt wurde, bietet:
- Das doppelte an Hyaluronsäure im Vergleich zur Originalformel
- Hydra Collagen und fortschrittliche VITISENSCE®-Technologie
- Bis zu 48 Stunden Feuchtigkeit
- Unterstützung der natürlichen Feuchtigkeitsspeicherung der Haut
Das Produkt kann mit einer DiamondGlow® Gesichtsbehandlung im Büro unter Verwendung des SkinMedica® HA5® Hydra Collagen Pro-Infusion Serum ergänzt werden. Klinische Studien zeigen, dass diese Kombination die Haut nach nur einer Anwendung dreimal strahlender, hydratisierter und sichtbar voller erscheinen lässt.
- Launch of a new advanced skin hydration product, potentially expanding market share
- Product claims to provide up to 48 hours of hydration, which may attract consumers
- Combination with in-office treatment shows significant visible improvements, potentially increasing product adoption
- None.
Insights
SkinMedica's new HA5® Hydra Collagen Replenish + Restore Hydrator represents a significant advancement in topical skin hydration. The product's formulation, featuring double the hyaluronic acid content and the addition of Hydra Collagen, addresses a important aspect of skin health. The Advanced VITISENSCE® Technology is particularly noteworthy, as it supports the skin's natural moisture retention mechanisms.
The claimed 48-hour hydration duration is impressive, suggesting potential for improved user compliance and sustained skin benefits. However, it's important to note that individual results may vary based on skin type and environmental factors. The synergistic effect with DiamondGlow® treatments indicates a holistic approach to skin care, potentially enhancing product efficacy.
This product launch signifies Allergan Aesthetics' strategic move to capitalize on the growing demand for advanced skincare solutions. The
The combination of at-home and in-office treatments creates a comprehensive skincare ecosystem, potentially driving revenue across multiple channels. However, the success of this product will largely depend on consumer education and the ability to differentiate it in a crowded market. The emphasis on clinical studies and dermatologist endorsement should help build credibility and justify the premium pricing.
- SkinMedica®, by the makers of BOTOX® Cosmetic (onabotulinumtoxinA) launches the first and only product to use a proprietary complex of five forms of Hyaluronic Acid (HA) and Hydra Collagen, plus Advanced VITISENSCE® Technology for deeper hydration
"We revolutionized the way people approached skin hydration in 2016 with the launch of our first HA5® Rejuvenating Hydrator, which continues to win industry awards and be a consumer favorite," said Jasson Gilmore, Senior Vice President of
The new SkinMedica® HA5® Hydra Collagen Replenish + Restore Hydrator has double the amount of hyaluronic acid than the original and now contains Hydra Collagen and Advanced VITISENSCE® Technology, which support the skin's natural ability to attract and retain moisture while providing instant hydration and smoothness. The product is appropriate for all skin types, helps fortify the skin barrier, and provides hydration for up to 48 hours1.
For optimal results, HA5® Hydra Collagen Replenish + Restore Hydrator can be complemented with an in-office DiamondGlow® facial using SkinMedica® HA5® Hydra Collagen Pro-Infusion Serum. Clinical studies show that participants using both the at-home and in-office treatment reported their skin appeared three-times more radiant, more hydrated, and visibly plumper after just one use1.
"Regardless of age, gender, or ethnicity, people experience dehydrated skin at some point. Skin hydration is critical for skin that not only looks smooth and radiant, but also feels healthy and firm," said Dr. Shannon Humphrey, board-certified dermatologist. "Daily application of the HA5® Hydra Collagen Hydrator, supplemented with DiamondGlow® treatments every 4-6 weeks is an effective combination that delivers radiant, glowing, and hydrated skin."
SkinMedica® HA5® Hydra Collagen Replenish + Restore Hydrator MSRP
To learn more and earn points on your favorite aesthetic treatments, including SkinMedica®, join Allē, the number one aesthetics loyalty program at Alle.com.
About Allergan Aesthetics
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skincare, and more. Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch. For more information, visit www.allerganaesthetics.com
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
Forward-Looking Statements
Some statements in this news release are, or may be considered, forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. The words "believe," "expect," "anticipate," "project" and similar expressions and uses of future or conditional verbs, generally identify forward-looking statements. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. Such risks and uncertainties include, but are not limited to, challenges to intellectual property, competition from other products, difficulties inherent in the research and development process, adverse litigation or government action, and changes to laws and regulations applicable to our industry. Additional information about the economic, competitive, governmental, technological and other factors that may affect AbbVie's operations is set forth in Item 1A, "Risk Factors," of AbbVie's 2023 Annual Report on Form 10-K, which has been filed with the Securities and Exchange Commission, as updated by its subsequent Quarterly Reports on Form 10-Q. AbbVie undertakes no obligation, and specifically declines, to release publicly any revisions to forward-looking statements as a result of subsequent events or developments, except as required by law.
BOTOX® COSMETIC IMPORTANT SAFETY INFORMATION AND APPROVED USES
Approved Uses
BOTOX® Cosmetic is a prescription medicine that is injected into muscles and used to temporarily improve the look of moderate to severe forehead lines, crow's feet lines, and frown lines between the eyebrows in adults.
IMPORTANT SAFETY INFORMATION
BOTOX® Cosmetic may cause serious side effects that can be life threatening. Get medical help right away if you have any of these problems any time (hours to weeks) after injection of BOTOX® Cosmetic:
- Problems swallowing, speaking, or breathing, due to weakening of associated muscles, can be severe and result in loss of life. You are at the highest risk if these problems are pre-existing before injection. Swallowing problems may last for several months.
- Spread of toxin effects. The effect of botulinum toxin may affect areas away from the injection site and cause serious symptoms including: loss of strength and all-over muscle weakness, double vision, blurred vision and drooping eyelids, hoarseness or change or loss of voice, trouble saying words clearly, loss of bladder control, trouble breathing, and trouble swallowing.
BOTOX® Cosmetic dosing units are not the same as, or comparable to, any other botulinum toxin product.
There has not been a confirmed serious case of spread of toxin effect when BOTOX® Cosmetic has been used at the recommended dose to treat frown lines, crow's feet lines, and/or forehead lines.
BOTOX® Cosmetic may cause loss of strength or general muscle weakness, vision problems, or dizziness within hours to weeks of taking BOTOX® Cosmetic. If this happens, do not drive a car, operate machinery, or do other dangerous activities.
Serious and/or immediate allergic reactions have been reported. They include: itching, rash, red itchy welts, wheezing, asthma symptoms, or dizziness or feeling faint. Get medical help right away if you are wheezing or have asthma symptoms, or if you become dizzy or faint.
Do not receive BOTOX® Cosmetic if you: are allergic to any of the ingredients in BOTOX® Cosmetic (see Medication Guide for ingredients); had an allergic reaction to any other botulinum toxin product such as Myobloc® (rimabotulinumtoxinB), Dysport® (abobotulinumtoxinA), or Xeomin® (incobotulinumtoxinA); have a skin infection at the planned injection site.
Tell your doctor about all your muscle or nerve conditions, such as ALS or Lou Gehrig's disease, myasthenia gravis, or Lambert-Eaton syndrome, as you may be at increased risk of serious side effects including difficulty swallowing and difficulty breathing from typical doses of BOTOX® Cosmetic.
Tell your doctor about all your medical conditions, including: plans to have surgery; had surgery on your face; have trouble raising your eyebrows; drooping eyelids; any other abnormal facial change; are pregnant or plan to become pregnant (it is not known if BOTOX® Cosmetic can harm your unborn baby); are breast-feeding or plan to (it is not known if BOTOX® Cosmetic passes into breast milk).
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Using BOTOX® Cosmetic with certain other medicines may cause serious side effects. Do not start any new medicines until you have told your doctor that you have received BOTOX® Cosmetic in the past.
Tell your doctor if you have received any other botulinum toxin product in the last 4 months; have received injections of botulinum toxin such as Myobloc®, Dysport®, or Xeomin® in the past (tell your doctor exactly which product you received); have recently received an antibiotic by injection; take muscle relaxants; take an allergy or cold medicine; take a sleep medicine; take aspirin-like products or blood thinners.
Other side effects of BOTOX® Cosmetic include: dry mouth; discomfort or pain at the injection site; tiredness; headache; neck pain; and eye problems: double vision, blurred vision, decreased eyesight, drooping eyelids and eyebrows, swelling of your eyelids and dry eyes.
For more information refer to the Medication Guide or talk with your doctor.
To report a side effect, please call Allergan at 1-800-678-1605.
Please see BOTOX® Cosmetic full Product Information including Boxed Warning and Medication Guide.
DiamondGlow® Important Information
Uses
The DiamondGlow® device is a general dermabrasion device that gently removes the top layer of skin and delivers topical cosmetic serums onto the skin.
Important Safety Information
The DiamondGlow® treatment is not for everyone. You should not have a DiamondGlow® treatment if you have compromised skin quality. Tell your provider if you are pregnant or lactating, or if you have any medical conditions, including allergies, and if you are using topical medications on the area to be treated.
Typical side effects include a scratchy, stinging sensation during the treatment and temporary tightness, redness or slight swelling after the treatment. Rare serious side effects may also occur and include severe skin irritation and allergic reactions.
SkinMedica® Pro-Infusion Serums Disclaimer
SkinMedica® Pro-Infusion Serums are intended to meet the FDA's definition of a cosmetic product, an article applied to the human body to cleanse, beautify, promote attractiveness, and alter appearances. These products are not intended to be drugs that diagnose, treat, cure, or prevent any disease or condition. These products have not been approved by the FDA and the statements have not been evaluated by the FDA.
Please talk to your provider for additional information.
SkinMedica® Important Information
Most SkinMedica® products are intended to meet the FDA's definition of a cosmetic product, an article applied to the human body to cleanse, beautify, promote attractiveness, and alter appearances. These SkinMedica® products are not intended to be drug products that diagnose, treat, cure, or prevent any disease or condition. These products have not been approved by the FDA and the statements have not been evaluated by the FDA.
For more information, please talk to your provider or visit SkinMedica.com and DiamondGlow.com. To report an adverse reaction, please call Allergan at 1-800-433-8871.
References:
- Data on file at SkinMedica ®
View original content to download multimedia:https://www.prnewswire.com/news-releases/skinmedica-revolutionizes-skin-hydration-with-the-introduction-of-ha5-hydra-collagen-replenish--restore-hydrator-302230995.html
SOURCE AbbVie
FAQ
What is the new product launched by SkinMedica and how does it relate to AbbVie (ABBV)?
How long does the new SkinMedica HA5® Hydra Collagen Replenish + Restore Hydrator provide hydration?
What are the key ingredients in SkinMedica's new HA5® Hydra Collagen Replenish + Restore Hydrator?
What is the retail price of SkinMedica's new HA5® Hydra Collagen Replenish + Restore Hydrator?
